| (USD) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -21.23M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, CTXR returned -57.4% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -26.1% |
| 1 year | -57.4% |
| 5 years | -99.0% |
| 10 years | -99.8% |
| All-time high | $937.50 (Mar 2016) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in CTXR would be worth today ›No. Citius Pharmaceuticals, Inc. has not paid a dividend in the past 12 months.
Citius Pharmaceuticals, Inc. stock trades on NASDAQ under the ticker symbol CTXR.
Citius Pharmaceuticals, Inc. is part of the Healthcare sector.
Citius Pharmaceuticals, Inc. has a market cap of 15.77M USD, based on the latest quote.
